Christopher T. Cox

PARTNER

Chris represents clients in a wide array of corporate and financial matters, with particular emphasis on mergers and acquisitions and corporate governance. He has represented public and private acquirers, targets, investment banks and private equity sponsors in connection with negotiated mergers and acquisitions, restructurings, joint ventures and proxy contests. He has also represented foreign and domestic entities in many aspects of cross-border business transactions.

Chris counsels clients on a broad range of corporate, securities and business-related matters and matters affecting corporate policy and strategy, including directors’ duties and responsibilities and other aspects of corporate governance, disclosure issues, corporate compliance matters, issues related to Sarbanes-Oxley compliance and financing transactions. He is recognized for his work in corporate and securities transactions by the Legal500 (2007).

Chris has worked extensively in the pharmaceutical industry, representing clients in public and private mergers and acquisitions, joint ventures, restructurings and all aspects of corporate finance.

Chris became a partner in 2001.